Aleve 200 mg caplets: Recalled from wholesale (Distribution Error)
Brand(s)
Last updated
Summary
Product
Aleve
Issue
Health products - Other
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Aleve |
Aleve |
DIN 02301733 |
Caplets |
220 mg |
NAAEWF2 |
Issue
Customer-returned products were inadvertently reintroduced into saleable inventory and distributed to the wholesale level.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Bayer Inc.
2920 Matheson Blvd. E
Mississauga, ON L4W 5R6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-82781
Get notified
Receive emails about new and updated recall and safety alerts.